Company Filing History:
2 out of 5,094 
2 out of 2 
2 out of 7 Years Active: 2008-2011
Title: The Innovations of Pascal Torregrossa
Introduction
Pascal Torregrossa is a notable inventor based in Marseilles, France. He has made significant contributions to the field of neurodegenerative diseases through his innovative research and patents. With a total of 2 patents, his work focuses on the modulation of neural cell adhesion molecule (NCAM) functions.
Latest Patents
Torregrossa's latest patents involve the use of poly-α2,8-sialic acid mimetic peptides to modulate NCAM functions. The first patent describes a peptide consisting of 5 to 30 amino acid residues, preferably 9 to 15, most preferably about 12 amino acid residues. This peptide comprises a B epitope of a poly-α2,8 sialic acid attached to NCAM, which is recognized by an anti-poly-α2,8 sialic acid (PSA) antibody. The invention aims to prepare a medicament for modulating NCAM functions, which can be administered for the prevention and/or treatment of neurodegenerative diseases, brain and spine lesions, age-related learning and memory problems, and cancer. The second patent reiterates similar findings and applications, emphasizing the importance of these peptides in medical treatments.
Career Highlights
Throughout his career, Torregrossa has worked with esteemed organizations such as the Centre National De La Recherche Scientifique and Schafer-n. His experience in these institutions has allowed him to advance his research and contribute to significant scientific advancements.
Collaborations
Some of his notable coworkers include Melitta Schachner and Claus Schafer Nielsen. Their collaborative efforts have further enriched the research landscape in which Torregrossa operates.
Conclusion
Pascal Torregrossa's innovative work in the field of neurodegenerative diseases showcases his dedication to advancing medical science. His patents reflect a commitment to developing effective treatments for complex health issues.